Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Abiraterone Acetate

Zytiga Prednisone Combo Metastatic Castration-Resistant Prostate Cancer Trial Unblinded

A new statement by Janssen Research & Development, LLC informs that they have unblinded the Phase 3 study, COU-AA-302, which shows that Zytiga (abiraterone acetate), when taken alongside prednisone, is effective in treating mildly symptomatic or asymptomatic patients who are suffering from metastatic castration-resistant prostate cancer (CRPC) and have not gone through chemotherapy. … Zytiga Prednisone Combo Metastatic Castration-Resistant Prostate Cancer Trial Unblinded   



prepucial stones1 - caliceal calculi1 - renal cell carcinoma5 - voiding dysfunction5 - prostate biopsy4 - intermittent therapy1 - new england journal of medicine2 - cancer treatment3 - low-grade prostate cancer2 - androgen-deprivation therapy1 - ccrcc1 - rheumatoid arthritis2 - section of nephrology1 - urinary total arsenic level1 - robotic stereotactic radiosurgery1 - anal sphincter1 - journal pediatric nephrology1 - laparoscopic partial nephrectomy1 - onset1 - kidney transplantation9 - urinary incontinence2 - creatinine levels1 - adpkd3 - wegener's granulomatosis2 - inherited kidney disease2 - focal segmental glomerulosclerosis2 - urological diseases1 - ascorbic acid1 - cystine lithiasis1 - aus1 -